GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Escalon Medical Corp (OTCPK:ESMC) » Definitions » EBIT

Escalon Medical (Escalon Medical) EBIT : $-0.04 Mil (TTM As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Escalon Medical EBIT?

Escalon Medical's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-0.16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.04 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Escalon Medical's annualized ROC % for the quarter that ended in Mar. 2024 was -26.31%. Escalon Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -34.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Escalon Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -1.96%.


Escalon Medical EBIT Historical Data

The historical data trend for Escalon Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Escalon Medical EBIT Chart

Escalon Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.23 -0.64 -0.03 0.04 0.48

Escalon Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.21 -0.02 -0.07 -0.16

Competitive Comparison of Escalon Medical's EBIT

For the Medical Devices subindustry, Escalon Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Escalon Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Escalon Medical's EV-to-EBIT falls into.



Escalon Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Escalon Medical  (OTCPK:ESMC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Escalon Medical's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-0.628 * ( 1 - 0% )/( (2.559 + 2.214)/ 2 )
=-0.628/2.3865
=-26.31 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Escalon Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.628/( ( (0.414 + max(1.617, 0)) + (0.33 + max(1.277, 0)) )/ 2 )
=-0.628/( ( 2.031 + 1.607 )/ 2 )
=-0.628/1.819
=-34.52 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.904 + 1.408 + 0.467) - (1.757 + 0.316 + 0.089)
=1.617

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.359 + 1.805 + 0.423) - (1.82 + 0.403 + 0.087)
=1.277

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Escalon Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-0.039/1.992
=-1.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Escalon Medical EBIT Related Terms

Thank you for viewing the detailed overview of Escalon Medical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Escalon Medical (Escalon Medical) Business Description

Traded in Other Exchanges
N/A
Address
435 Devon Park Drive, Suite 824, Wayne, PA, USA, 19087
Escalon Medical Corp operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Color/Fluorescein Angiography Digital Imaging Systems, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
Executives
David James Jacovini director 120 PINE STREET, PHILADELPHIA PA 19106
John Dogum director 1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103
Richard J Depiano director 435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087
Lisa A Napolitano director 351 EAST CONESTOGA ROAD, WAYNE PA 19087
C Sean Closkey director 1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103
C Todd Trusk director 1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301
Robert Michael O'connor officer: Chief Financial Officer 53 SORREL RUN, MT. LAUREL NJ 08054
Anthony J Coppola director 1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205
Federman Jay L Md director 501 N. ESSEX AVENUE, NARBERTH PA 19072
Kwan William L G director 351 EAST CONESTOGA ROAD, WAYNE PA 19087
Mark Wallace officer: Chief Operating Officer 565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087
Fred G Choate director 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080
Depiano Richard J Jr officer: President 575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087
Berkowitz David officer: Principal Accounting Officer 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087
Mark H Karsch officer: CFO 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087

Escalon Medical (Escalon Medical) Headlines